Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification

Morten Baltzer Houlind*, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Dalhoff, Per Damkier, Anne B. Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalBasic and Clinical Pharmacology and Toxicology
Volume134
Issue number5
Pages (from-to)756-763
ISSN1742-7835
DOIs
Publication statusPublished - May 2024

Keywords

  • CYP2C19
  • CYP2C9
  • CYP2D6
  • genotype
  • genotype-phenotype association
  • pharmacogenomics
  • phenotype
  • Cytochrome P-450 CYP2C9/genetics
  • Genotype
  • Pharmacogenomic Testing
  • Phenotype
  • Denmark
  • Cytochrome P-450 CYP2C19/genetics
  • Cytochrome P-450 CYP2D6/genetics

Cite this